Copyright 2009 Medical News Today Latest Prostate / Prostate Cancer News From Medical News Today. http://www.medicalnewstoday.com/sections/prostate/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Sun, 05 Jul 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/156340.php http://www.medicalnewstoday.com/articles/156340.php An Experimental cancer therapy for prostate cancer may be able to treat men without surgery and offer fewer side effects according to the results of a UK study published in the British Journal of Cancer* today (Wednesday). A group of 172 men with prostate cancer that had not spread were treated under general anaesthetic with Prostate / Prostate Cancer Fri, 03 Jul 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/156275.php http://www.medicalnewstoday.com/articles/156275.php Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the July 1 issue of the International Journal of Radiation Oncology Biology Physics, the official journal of the American Society for Radiation Oncology (ASTRO). Brachytherapy is the placement of radioactive sources in or just next to a tumor either permanently or temporarily, depending upon the cancer. Prostate / Prostate Cancer Fri, 03 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/156227.php http://www.medicalnewstoday.com/articles/156227.php Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis. Prostate / Prostate Cancer Thu, 02 Jul 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/156109.php http://www.medicalnewstoday.com/articles/156109.php One of the most controversial issues in men's health is whether men should routinely have a blood test for prostate-specific antigen (PSA) to screen for prostate cancer. Some experts argue that PSA testing saves lives by helping detect this common form of cancer early. Others say it triggers unnecessary treatment that disrupts many more lives than it saves. Prostate / Prostate Cancer Thu, 02 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/156057.php http://www.medicalnewstoday.com/articles/156057.php A just published Review in the publication "Expert Opinion on Investigational Drugs", Volume 18, Issue 7 2009, confirms the previous published information on PROSTVAC(TM). This is the most comprehensive and updated Review on PROSTVAC(TM) so far. Prostate / Prostate Cancer Wed, 01 Jul 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/155976.php http://www.medicalnewstoday.com/articles/155976.php Dr. Gary D. Kao testified Monday about botched prostate cancer treatment he gave to patients at a Veterans Affairs hospital run by the University of Pennsylvania. The Prostate / Prostate Cancer Wed, 01 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/155891.php http://www.medicalnewstoday.com/articles/155891.php The July issue of European Urology, the official journal of the European Association of Urology, features an editorial by Lars Holmberg comparing the results from the European Randomised Study of Screening for Prostate Cancer (ERSPC) with the results from the Prostate, Lung, Colorectal and Prostate / Prostate Cancer Tue, 30 Jun 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/155829.php http://www.medicalnewstoday.com/articles/155829.php The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA: A Cancer Journal for Clinicians. Authored by Otis W. Brawley, M.D. of the American Cancer Society and Donna Ankerst, Ph.D. and Ian M. Thompson, M.D. Prostate / Prostate Cancer Tue, 30 Jun 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/155767.php http://www.medicalnewstoday.com/articles/155767.php Specific variations or mutations in a particular can gene raise a man's risk of familial, or inherited, testicular germ-cell cancer, the most common form of this disease, according to new research by scientists at the National Institutes of Health. This is only the second gene to be identified that affects the risk of familial testicular cancer, and the first gene in a key biochemical pathway. The study appears in the July 2009 Cancer Research. Cancer / Oncology Mon, 29 Jun 2009 11:00:00 PDT http://www.medicalnewstoday.com/articles/155728.php http://www.medicalnewstoday.com/articles/155728.php The recently released results of two large randomized trials suggest there are no big benefits from prostate cancer screening, and if anything, they are quite small, says a new report by US researchers. And an accompanying editorial goes so far as to suggest that while screening has doubled the risk of a diagnosis, it has done little to reduce the risk of death from prostate cancer. Prostate / Prostate Cancer Sat, 27 Jun 2009 08:00:00 PDT http://www.medicalnewstoday.com/articles/155599.php http://www.medicalnewstoday.com/articles/155599.php UroToday.com - Prostate and breast cancer appear to be homologous cancer in males and females respectively. Both cancers share hormone etiologies and are treated with hormonal manipulation. The incidence of these two hormone-dependent cancers has steadily risen throughout the twentieth century. Prostate / Prostate Cancer Fri, 26 Jun 2009 07:00:00 PDT http://www.medicalnewstoday.com/articles/155525.php http://www.medicalnewstoday.com/articles/155525.php The drug, called olaparib, specifically targets hereditary cancer caused by faulty BRCA1 and BRCA2 genes. The small scale patient trial has shown remarkable benefit for patients with breast, ovarian and prostate cancer. The trial was carried out by The Institute of Cancer Research with the Royal Marsden Hospital, working with pharmaceutical company AstraZeneca, with results published in the New England Journal of Medicine on 9 July 2009. Breast Cancer Fri, 26 Jun 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/155428.php http://www.medicalnewstoday.com/articles/155428.php Higher selenium levels in the blood may worsen prostate cancer in some men who already have the disease, according to a study by researchers at Dana-Farber Cancer Institute and the University of California, San Francisco. A higher risk of more-aggressive prostate cancer was seen in men with a certain genetic variant found in about 75 percent of the prostate cancer patients in the study. Prostate / Prostate Cancer Fri, 26 Jun 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/155406.php http://www.medicalnewstoday.com/articles/155406.php Joel B. Nelson, M.D., chairman of the University of Pittsburgh Medical Center's (UPMC) Department of Urology, performed his 2,000th radical prostatectomy at UPMC Shadyside, a milestone achieved by only a handful of surgeons worldwide. Radical prostatectomy, or removal of the entire prostate gland, is the most common treatment for patients with localized prostate cancer. Prostate / Prostate Cancer Thu, 25 Jun 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/155294.php http://www.medicalnewstoday.com/articles/155294.php Scientists at The Institute of Cancer Research (ICR) and The Royal Marsden Hospital, working with pharmaceutical company AstraZeneca, have completed a Phase I clinical trial demonstrating the great promise of a completely new type of cancer treatment. The results are announced today in The New England Journal of Medicine. Breast Cancer Thu, 25 Jun 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/155240.php http://www.medicalnewstoday.com/articles/155240.php FIRMAGON® (degarelix) a new fast-acting hormone treatment for advanced prostate cancer is being offically launched in the UK yesterday at the British Association of Urological Surgeons Annual Meeting in Glasgow. Prostate cancer is the most common cancer in men, and over 35,000 cases a year (1) are diagnosed in the UK , with 10,239 men dying in 2007.(2) Prostate cancer is fuelled by the male hormone testosterone. Prostate / Prostate Cancer Thu, 25 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/155283.php http://www.medicalnewstoday.com/articles/155283.php Scientists in the US have discovered that cancer tumors that don't spread to other parts of the body secrete a protein called prosaposin and that metastatic tumors, which do spread, don't secrete much of it. They suggest this discovery could lead the way to developing new treatments that stop cancers from spreading. The research was the work of a team at Children's Hospital Boston, Massachusetts, led by Dr Randoph S. Cancer / Oncology Wed, 24 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/155029.php http://www.medicalnewstoday.com/articles/155029.php Collaboration in prostate cancer translational research in Europe is not only vital to sustain the progress achieved in recent years but also to streamline current efforts between researchers and clinicians and avoid duplication or overlaps. This was amongst the goals of the two-day Prostate Cancer Translational Research in Europe (PCTRE) Meeting which opened recently in Amsterdam, The Netherlands. Prostate / Prostate Cancer Mon, 22 Jun 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/154803.php http://www.medicalnewstoday.com/articles/154803.php US researchers found that men with prostate cancer who consumed a mix of polyphenols found in green tea experienced a significant reduction in serum markers such as PSA, VGF and VEGF that predict the progression of prostate cancer. Prostate / Prostate Cancer Mon, 22 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/154748.php http://www.medicalnewstoday.com/articles/154748.php UroToday.com - In the online issue of the World Journal of Urology, a group headed by Professor Markus Hohenfellner compared the outcomes of radical prostatectomy (RP) in men younger and older than age 70 years. They suggest that in well-selected men over age 70 years, the outcomes are comparable. The study cohort consisted of 626 men who underwent RP at their institution between 1990 and 2006. Prostate / Prostate Cancer Mon, 22 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/154749.php http://www.medicalnewstoday.com/articles/154749.php UroToday.com - Men undergoing surgical interventions for BPH are still at risk for subsequent development of prostate cancer (CaP) due to residual tissue. It is suggested that PSA decreases approximately 0.1-0.3ng/ml for every 1g of prostate tissue removed. In the online edition of Urology, Dr. Prostate / Prostate Cancer Mon, 22 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/154752.php http://www.medicalnewstoday.com/articles/154752.php BERKELEY, CA (UroToday.com) - I was trained and board certified as a urologist (University of Virginia) and pathologist (Cornell and UVA) and arrived at Johns Hopkins in 1991 to do a research fellowship with Dr. William B. Isaacs, funded by the American Foundation for Urologic Disease (now the AUA Foundation). Prostate / Prostate Cancer Sat, 20 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/154716.php http://www.medicalnewstoday.com/articles/154716.php According to results of a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, men with prostate cancer who consumed the active compounds in green tea demonstrated a significant reduction in serum markers predictive of prostate cancer progression. Prostate / Prostate Cancer Sat, 20 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/154712.php http://www.medicalnewstoday.com/articles/154712.php Two Mayo Clinic patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental drug therapy that was used in combination with standardized hormone treatment and radiation therapy. The men were participating in a clinical trial of an immunotherapeutic agent called MDX-010 or ipilimumab. Prostate / Prostate Cancer Sat, 20 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/154722.php http://www.medicalnewstoday.com/articles/154722.php A study carried out by researchers in the Feist-Weiller Cancer Center, LSU Health Sciences Center-Shreveport, USA, found that men with prostate cancer who consumed the active compounds found in green tea had considerable reduction in serum markers predictive of prostate cancer progression. The study has been published in Cancer Prevention Research, an American Association for Cancer Research journal. James A. Cardelli, Ph.D. Prostate / Prostate Cancer